Dr. Joel Schlessinger discusses ATX-101, a new drug to treat double chins
ATX-101, a new treatment designed to address excessive fat on the chin, was recommended for approval by an FDA advisory committee this week. Along with his staff at the Advanced Skin Research Center, Dr. Joel Schlessinger has conducted studies on this treatment over the past several years. Dr. Schlessinger has enjoyed working with ATX-101 since the beginning and is excited to add it to his practice.

ATX-101 offers a new way to treat excessive fat on the chin, Dr. Joel Schlessinger says.

This in-office procedure is a new treatment option to address double chins without invasive surgery. Dr. Joel Schlessinger has seen great results during clinical trials and is looking forward to offering ATX-101 for his patients.

“Based on the clinical trials, I am quite excited to have this in my clinic and will be using it for many of my patients who have issues with excessive fat on the chin,” he says.

Dr. Joel Schlessinger says this treatment is ideal for patients who want to address chin fat without liposuction.

“I don’t think it will entirely take away the need for chin liposuction, but it will clearly treat many individuals who have too little fat for liposuction but still have a clear need,” he says. “This is a huge bonus for our specialty and patients!”

The studies performed by Dr. Joel Schlessinger played an integral role in ATX-101’s success.

Dr. Joel Schlessinger and his team worked hard to see ATX-101 through its preliminary stages. Now with the treatment one step closer to receiving FDA approval, Dr. Schlessinger is excited to add it to his practice.

“Having worked on ATX-101 since 2007, it feels like my ‘child’ has been born at this point,” he says. “It has been a wonderful experience to be involved with this exciting new treatment option from the beginning.”

Do you have a question for Dr. Joel Schlessinger? Share with us in the comments.

Posted Friday, April 3rd, 2015 at 2:00 pm
Filed Under Category: Cosmetic Surgery, Research and Studies
You can skip to the end and leave a response. Pinging is currently not allowed.

0

Leave a Reply